I

IDEAYA Biosciences
D

IDYA

26.750
USD
0.12
(0.45%)
Market Closed
Volume
26,893
EPS
-2
Div Yield
-
P/E
-11
Market Cap
2,312,050,623
OverviewSignalsIdeasNews
Related Instruments
    A
    ARVN
    -2.440
    (-9.78%)
    22.500 USD
    C
    CRNC
    -0.09500
    (-3.02%)
    3.05000 USD
    C
    CUE
    -0.26000
    (-17.22%)
    1.25000 USD
    F
    FATE
    -0.04500
    (-2.17%)
    2.02500 USD
    I
    ICAD
    -0.14000
    (-7.87%)
    1.64000 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    R
    RETA
    0
    (0%)
    0.000000 USD
    T
    TDOC
    0.23500
    (2.62%)
    9.19500 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: IDEAYA Biosciences

Sector: Healthcare
Industry: Biotechnology
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.